Screener
Viridian Therapeutics, Inc. VRDN Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Viridian Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
FAQ
- What is Viridian Therapeutics, Inc.'s asset turnover?
- Viridian Therapeutics, Inc. (VRDN) reported asset turnover of 0.1× in Q2 2026.
- How has Viridian Therapeutics, Inc.'s asset turnover changed year-over-year?
- Viridian Therapeutics, Inc.'s asset turnover increased by 16840.0% year-over-year, from 0× to 0.1×.
- What is the long-term trend for Viridian Therapeutics, Inc.'s asset turnover?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s asset turnover has grown at a 46.0% compound annual growth rate (CAGR), from 0× to 0.1×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Viridian Therapeutics, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude